Cargando…

Tumor-infiltrating lymphocytes for melanoma immunotherapy

Detalles Bibliográficos
Autores principales:	Kepp, Oliver, Liu, Peng, Zitvogel, Laurence, Kroemer, Guido
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9908292/ https://www.ncbi.nlm.nih.gov/pubmed/36776522 http://dx.doi.org/10.1080/2162402X.2023.2175506

Ejemplares similares

Prevention and treatment of cancers by tumor antigen-expressing Staphylococcus epidermidis
por: Kepp, Oliver, et al.
Publicado: (2023)

Lurbinectedin: an FDA-approved inducer of immunogenic cell death for the treatment of small-cell lung cancer
por: Kepp, Oliver, et al.
Publicado: (2020)

Immune infiltrate in cancer
por: Stoll, Gautier, et al.
Publicado: (2015)

Trial Watch: combination of tyrosine kinase inhibitors (TKIs) and immunotherapy
por: Petrazzuolo, Adriana, et al.
Publicado: (2022)

Immunostimulatory effects of vitamin B5 improve anticancer immunotherapy
por: Bourgin, Melanie, et al.
Publicado: (2022)

Microbiota-associated immunotherapy resistance caused by deficient PD-L2 - RGMb signaling
por: Fidelle, Marine, et al.
Publicado: (2023)

Victories and deceptions in tumor immunology: Stimuvax(®)
por: Kroemer, Guido, et al.
Publicado: (2013)

Boosting the immunotherapy response by nutritional interventions
por: Zitvogel, Laurence, et al.
Publicado: (2022)

Cross-reactivity between cancer and microbial antigens
por: Zitvogel, Laurence, et al.
Publicado: (2021)

Targeting PD-1/PD-L1 interactions for cancer immunotherapy
por: Zitvogel, Laurence, et al.
Publicado: (2012)

Novel galenic formulations for delivering immunochemotherapies: kill intelligently, remove the checkpoint and let the T cells in!
por: Kepp, Oliver, et al.
Publicado: (2020)

A novel platinum-based chemotherapeutic inducing immunogenic cell death
por: Kepp, Oliver, et al.
Publicado: (2020)

Small cell lung cancer responds to immunogenic chemotherapy followed by PD-1 blockade
por: Kroemer, Guido, et al.
Publicado: (2021)

Radiochemotherapy-induced elevations of plasma HMGB1 levels predict therapeutic responses in cancer patients
por: Kroemer, Guido, et al.
Publicado: (2021)

PD-1 blockade synergizes with oxaliplatin-based, but not cisplatin-based, chemotherapy of gastric cancer
por: Liu, Peng, et al.
Publicado: (2022)

Arsenic trioxide as an inducer of immunogenic cell death
por: Kepp, Oliver, et al.
Publicado: (2023)

Secreted calreticulin mutants subvert anticancer immunosurveillance
por: Liu, Peng, et al.
Publicado: (2019)

Immunological effects of chemotherapy in spontaneous breast cancers
por: Kroemer, Guido, et al.
Publicado: (2013)

Tumor necrosis factor is dispensable for the success of immunogenic anticancer chemotherapy
por: Ma, Yuting, et al.
Publicado: (2013)

Failure of immunosurveillance accelerates aging
por: Perez-Lanzon, Maria, et al.
Publicado: (2019)

TP53 and MTOR crosstalk to regulate cellular senescence
por: Galluzzi, Lorenzo, et al.
Publicado: (2010)

Immunogenic cell death inducers as anticancer agents
por: Kepp, Oliver, et al.
Publicado: (2014)

Immune effectors required for the therapeutic activity of vorinostat
por: Kepp, Oliver, et al.
Publicado: (2013)

Ferroptosis becomes immunogenic: implications for anticancer treatments
por: Tang, Daolin, et al.
Publicado: (2020)

A genotype-phenotype screening system using conditionally immortalized immature dendritic cells
por: Zhao, Liwei, et al.
Publicado: (2021)

COVID-19: a challenge for oncology services
por: Routy, Bertrand, et al.
Publicado: (2020)

Synthetic induction of immunogenic cell death by genetic stimulation of endoplasmic reticulum stress
por: Michaud, Mickaël, et al.
Publicado: (2014)

Bile acids regulate MAdCAM-1 expression to link the gut microbiota to cancer immunosurveillance
por: Fidelle, Marine, et al.
Publicado: (2023)

An unexpected link between immunogenic cell death and inhibition of gene transcription
por: Humeau, Juliette, et al.
Publicado: (2020)

The intimate relationship between gut microbiota and cancer immunotherapy
por: Elkrief, Arielle, et al.
Publicado: (2018)

Regulatory approval of photoimmunotherapy: photodynamic therapy that induces immunogenic cell death
por: Gomes-da-Silva, Lígia C., et al.
Publicado: (2020)

Trial watch: Cardiac glycosides and cancer therapy
por: Menger, Laurie, et al.
Publicado: (2013)

An anticancer therapy-elicited immunosurveillance system that eliminates tetraploid cells
por: Senovilla, Laura, et al.
Publicado: (2013)

Meta-analysis of organ-specific differences in the structure of the immune infiltrate in major malignancies
por: Stoll, Gautier, et al.
Publicado: (2015)

Impact of chemotactic factors and receptors on the cancer immune infiltrate: a bioinformatics study revealing homogeneity and heterogeneity among patient cohorts
por: Stoll, Gautier, et al.
Publicado: (2018)

Heating it up: Oncolytic viruses make tumors ‘hot’ and suitable for checkpoint blockade immunotherapies
por: Gujar, Shashi, et al.
Publicado: (2018)

Reinvigorating tumour-infiltrating lymphocytes from checkpoint inhibitor resistant melanomas
por: Silva, Inês Pires da, et al.
Publicado: (2018)

Trial watch: Peptide-based vaccines in anticancer therapy
por: Bezu, Lucillia, et al.
Publicado: (2018)

Histamine antagonists promote cancer immunosurveillance
por: Liu, Peng, et al.
Publicado: (2023)

Abscopal but desirable: The contribution of immune responses to the efficacy of radiotherapy
por: Kroemer, Guido, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_llnf3ua413171u9e119nlo7cae